56 results on '"Beasley, A. M."'
Search Results
2. International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node Positive Melanoma at Major Referral Centers
3. Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis
4. Enriching Nutrition Programs to Better Serve the Needs of a Diversifying Aging Population
5. Abstract P357: Relative Validity and Reliability of a Diet Risk Screener (DRS) for Clinical Practice
6. Abstract P361: Racial/Ethnic and Age Differences in Dietary Sources of Protein, NHANES, 2011 - 2016
7. Associations of social, physical, and financial factors with diet quality among older, community-dwelling women
8. Regional After-Action Review Among Local Health Department Personnel After Hurricane Matthew in Eastern North Carolina, United States
9. Twenty-Four–Hour Measures of Heart Rate–Corrected QT Interval, Peak-to-End of the T-Wave, and Peak-to-End of the T-Wave/Corrected QT Interval Ratio During Antipsychotic Treatment
10. Relationship of Sodium Intake and Blood Pressure Varies With Energy Intake
11. Quality of anticoagulation control and hemorrhage risk among African American and European American warfarin users
12. Abstract MP042: Higher Levels of Sodium Density (mg/kcal) are Associated With Increased Blood Pressure Independent of Absolute Sodium (mg): the DASH Sodium Trial
13. Abstract P234: The Relationship Between Polyphenols and Body Composition within the Hispanic Community Health Study/Study of Latinos Nutrition and Activity Study
14. Excessive Pulmonary Artery Systolic Pressure During Exercise in Adults with a History of Preterm Birth
15. Abstract 16445: Anticoagulation Control, Risk of Overanticoagulation and Major Hemorrhage Among Warfarin Users is Influenced by Race
16. Abstract 16324: Genetic Predisposition Influences Anticoagulation Control and Major Hemorrhage Among Warfarin Users
17. Loperamide Versus Psyllium Fiber for Treatment of Fecal Incontinence
18. Procedure Delegation by Attending Surgeons Performing Concurrent Operations in Academic Medical Centers
19. Targeting N-cadherin Increases Vascular Permeability and Differentially Activates AKT in Melanoma
20. Decreased Endothelial Progenitor Cells in Preeclampsia and Consequences for Developmental Programming
21. Changes in Physical Activity and Body Composition in Postmenopausal Women over Time
22. Simultaneous Diaphragm and Liver Resection: A Propensity-Matched Analysis of Postoperative Morbidity
23. Abstract WP289: The Impact of Infection on Neurological Deterioration and Outcome in Acute Ischemic Stroke Patients
24. A Multicenter Prospective Evaluation of the Clinical Utility of F-18 FDG-PET/CT in Patients With AJCC Stage IIIB or IIIC Extremity Melanoma
25. Abstract 3235: Low LDL is Associated with Hematoma Expansion in Chronic Daily Alcohol Users with Intracranial Hemorrhage
26. Abstract 3266: Nadir Hemoglobin Predicts Poor Functional Outcome and Death in ICH Patients
27. Abstract 3251: Relationship Between tPA and Factor VIII Levels in Patients with Acute Ischemic Stroke
28. Current Trends in Regional Therapy for Melanoma: Lessons Learned from 225 Regional Chemotherapy Treatments between 1995 and 2010 at a Single Institution
29. A Multi-Institutional Experience of Isolated Limb Infusion: Defining Response and Toxicity in the US
30. Fluoxetine and Adult Suicidality Revisited
31. All-Cause Treatment Discontinuation in Schizophrenia During Treatment With Olanzapine Relative to Other Antipsychotics
32. Is Quality of Life Among Minimally Symptomatic Patients With Schizophrenia Better Following Withdrawal or Continuation of Antipsychotic Treatment?
33. A Double-Blind, Randomized, Placebo-Controlled Trial of Olanzapine in the Prevention of Psychotic Relapse
34. Tadalafil has No Detrimental Effect on Human Spermatogenesis or Reproductive Hormones
35. Extrapyramidal symptom profiles assessed with the Drug-Induced Extrapyramidal Symptom Scale: comparison with Western scales in the clinical double-blind studies of schizophrenic patients treated with either olanzapine or haloperidol
36. Extrapyramidal symptom profiles assessed with the Drug-Induced Extrapyramidal Symptom Scale: comparison with Western scales in the clinical double-blind studies of schizophrenic patients treated with either olanzapine or haloperidol
37. Fluoxetine and Norfluoxetine Plasma Levels After Discontinuing Fluoxetine Therapy
38. Plasma Olanzapine and Clinical Response
39. Fluoxetine in Medically Stable, Depressed Geriatric Patients
40. Absence of a Relationship Between Adverse Events and Suicidality During Pharmacotherapy for Depression
41. Possible Monoamine Oxidase Inhibitor-Serotonin Uptake Inhibitor Interaction
42. Fluoxetine
43. Fluoxetine not associated with increased aggression in controlled clinical trials
44. The effects of renal and hepatic disease on the pharmacokinetics, renal tolerance, and risk-benefit profile of fluoxetine
45. Fluoxetine versus amitriptyline in the treatment of major depression
46. Fluoxetine
47. Fluoxetine and Suicide
48. Reply to Dr. Friedman
49. FLUOXETINE: ACTIVATING AND SEDATING EFFECTS AT MULTIPLE FIXED DOSES
50. High-Dose Fluoxetine
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.